Management of gynecologic oncology emergencies.
Gynecologic malignancies are the third most common cancer among women in the United States. Because of often subtle early findings, the diagnosis may not be made before the widespread dissemination of the disease. The Emergency Department physician will commonly encounter a woman with vaginal bleeding, pelvic pain, or a symptomatic abdominal mass. In this article, we have described the epidemiology, recognized patterns of spread, and associated findings of gynecologic tumors. The proper Emergency Department evaluation and management of these problems is emphasized with guidelines for the timing of referrals and consultation with the gynecologic oncologist. The treatment of gynecologic malignancies is often complicated and responsible for Emergency Department visits. The various modalities are addressed according to the organ systems affected and include sections on postoperative problems, gastrointestinal complaints, urologic complications of therapy, radiation therapy and its complications, with an emphasis on the most serious complications necessitating either careful outpatient management or hospital admission. As cost-containment pressure grows, we have included sections on chemotherapy and total parenteral nutrition, both of which are becoming common outpatient events for the cancer patient.
D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D004630:Emergencies; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy; D006801:Humans; D007415:Intestinal Obstruction / Q000209:etiology; D009102:Multiple Organ Failure / Q000209:etiology / Q000628:therapy; D009362:Neoplasm Metastasis; D010289:Parenteral Nutrition, Total / Q000009:adverse effects; D011183:Postoperative Complications / Q000628:therapy; D011247:Pregnancy; D011832:Radiation Injuries / Q000628:therapy; D014570:Urologic Diseases / Q000209:etiology / Q000628:therapy
D000970:Antineoplastic Agents